Drawing for CAPTELLIGENCE

USPTO serial 79154126

CAPTELLIGENCE

Reviewed by CopyMark Law Group

Reg. 4783934Status 404
Filing date
Status date
Registration date
Aug 4, 2015
Examiner
ROACH, APRIL K
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CAPTELLIGENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—
010Drug delivery systems for the deferred, controlled or immediate release of active substances of pharmaceutical preparationsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 12, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 26, 2019GPNXNOTIFICATION PROCESSED BY IB—
Nov 30, 2018GPNXNOTIFICATION PROCESSED BY IB—
Sep 14, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 14, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 13, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 13, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 13, 2016FIMPFINAL DISPOSITION PROCESSED—
Nov 4, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 4, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2015GPNXNOTIFICATION PROCESSED BY IB—
Apr 29, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 29, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 29, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 11, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 11, 2015ALIEASSIGNED TO LIE—
Mar 23, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 5, 2014RFNTREFUSAL PROCESSED BY IB—
Nov 17, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 17, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 14, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 13, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2014DOCKASSIGNED TO EXAMINER—
Nov 11, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 6, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance